TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Hepatitis C Medicines

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS National Services Scotland: "Hepatitis C Medicines". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS National Services ScotlandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS National Services Scotland
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS National Services Scotland. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
4.3Bids / Report
22.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 48 active published awards; 44 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS National Services Scotland
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published7 Feb 2022, 09:55 GMT
Last source update7 Feb 2022, 09:55 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-0313c0
What is being bought
The framework agreement is awarded for the supply of medicines used to treat Hepatitis C to NHS Scotland.
What changed
From the official release history
  1. Status changed to complete
    7 Feb 2022, 09:55 GMT
  2. Official notice release published
    7 Feb 2022, 09:55 GMT
  3. Buyer information updated
    7 Feb 2022, 09:55 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    Treatment Cost per Medicine
    Status not published
    Published valueNot published
    This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Treatment Spend Cap
    Status not published
    Published valueNot published
    This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    7 Feb 2022, 09:55 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £3,500,000
  5. Contract active
    Signed 7 Feb 2022, 00:00 GMT · £4,000,000
Commercial outcome and competition
Awards
AbbVie Ltd, Gilead Sciences Ltd, Merck Sharp & Dohme UK Ltd
Not published · Not published · active
AbbVie Ltd, Gilead Sciences Ltd
Not published · Not published · active
Contracts
Treatment Cost per Medicine
£3,500,000 · signed 7 Feb 2022, 00:00 GMT · active
Treatment Spend Cap
£4,000,000 · signed 7 Feb 2022, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS National Services Scotland

Contracting authority GB-FTS-11130
View buyer profile

  • NHS National Services Scotland
    buyer

    Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    Andrew.Stewart5@nhs.scot
    +44 7957280465

  • AbbVie Ltd
    supplier

    Abbvie House, Vanwall Business Park, Maidenhead, UK, SL6 4UB
    +44 7775116875

  • Gilead Sciences Ltd
    supplier

    280 High Holborn , Holborn, London, UK, WC1V 7EE
    +44 2036814526

  • Merck Sharp & Dohme UK Ltd
    supplier

    120 Moorgate, London, United Kingdom, HODDESDON, UK, EC2M 6UR.
    +44 1992455245

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThis VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015